Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Prabhakar P. Venkata"'
Autor:
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P. Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata, Viktor Drel, Bindu Santhamma, Swapna Konda, Xiaonan Li, Alondra Lee Rodriguez Sanchez, Hui Yan, Gangadhara R. Sareddy, Zhenming Xu, Brij B. Singh, Philip T. Valente, Yidong Chen, Zhao Lai, Manjeet Rao, Edward R. Kost, Tyler Curiel, Rajeshwar R. Tekmal, Hareesh B. Nair, Ratna K. Vadlamudi
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-18 (2024)
Abstract Of all gynecologic cancers, epithelial-ovarian cancer (OCa) stands out with the highest mortality rates. Despite all efforts, 90% of individuals who receive standard surgical and cytotoxic therapy experience disease recurrence. The precise m
Externí odkaz:
https://doaj.org/article/9ac36726d5db494b89c1884b726a9b5c
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/bfb2185d12c440adb24659a140cb2cd2
Autor:
Weiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar M. A. Pillai, Bindu Santhamma, Swapna Konda, Prabhakar Pitta Venkata, Logan Blankenship, Junhao Liu, Zexuan Liu, Kristin A. Altwegg, Behnam Ebrahimi, Uday P. Pratap, Xiaonan Li, Philip T. Valente, Edward Kost, Gangadhara R. Sareddy, Ratna K. Vadlamudi, Hareesh B. Nair, Rajeshwar R. Tekmal, Suryavathi Viswanadhapalli
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Endometrial cancer (EC) is the fourth most common cancer in women. Advanced-stage EC has limited treatment options with a poor prognosis. There is an unmet need for the identification of actionable drivers for the development of targeted the
Externí odkaz:
https://doaj.org/article/1cfca25be46f4749a68da61a6d728416
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Salvador Alejo, Bridgitte Palacios, Prabhakar Pitta Venkata, Yi He, Wenjing Li, Jessica Johnson, Sridharan Jayamohan, Ratna Vadlamudi, Gangadhara Sareddy
Publikováno v:
Journal of Clinical and Translational Science, Vol 7, Pp 90-90 (2023)
OBJECTIVES/GOALS: Glioblastoma (GBM) patients face a poor prognosis. Glioma stem cells (GSCs), a chemo resistant GBM subpopulation, possess enhanced DNA repair and elevated levels of epigenetic modifier KDM1A. This study aims to establish the signifi
Externí odkaz:
https://doaj.org/article/9a79c277822e47d9ad6b775e8f9a6f0f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Politics and Governance, 9, 4, 27-42, Climate Change and Security
External emergency assistance (EEA) provided in the aftermath of a disaster has costs and benefits to the donor and recipient countries. Donors benefit from quick recovery feedback effects from the trade and cultural links, and recipient countries ha
Externí odkaz:
https://www.ssoar.info/ssoar/handle/document/76475
Autor:
Daniel Van Den Berg, Rebecca Glans, Dorian De Koning, Fernando A. Kuipers, Jochem Lugtenburg, Kurian Polachan, Prabhakar T. Venkata, Chandramani Singh, Belma Turkovic, Bryan Van Wijk
Publikováno v:
IEEE Access, Vol 5, Pp 23502-23518 (2017)
The Tactile Internet presently constitutes a vision of an Internet over which, in addition to current communications modalities, a sense of touch can be transported. In that case, people would no longer need to be physically near the systems they ope
Externí odkaz:
https://doaj.org/article/881bfa186c2d4ad9ab0018f5d9929c2f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yi He, Salvador Alejo, Prabhakar P. Venkata, Jessica D. Johnson, Ilanna Loeffel, Julie Ann Martel, Uday P. Pratap, Suryavathi Viswanadhapalli, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Edward Kost, Gangadhara R. Sareddy
Publikováno v:
Cancer Research. 82:891-891
Background: Ovarian cancer (OCa) is the deadliest gynecologic cancer. Emerging studies suggest that ovarian cancer stem cells (OCSCs) contribute to tumor relapse and chemotherapy resistance. Recent studies demonstrate that OCa cells express estrogen